Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Cathie Wood’s ARK ETFs have made their daily trades for Tuesday, March 4th, 2025, with a series of notable buy and sell actions that reflect the investment firm’s ongoing strategy adjustments. The most significant move of the day was the sale of 558,280 shares of automation software company UiPath Inc (NYSE:PATH), distributed across ARKK, ARKQ, and ARKW ETFs, with a total dollar value of $6,565,372. This marked ARK’s largest trade by dollar value for the day.
In a noteworthy acquisition, ARK invested heavily in the software development company GitLab Inc (NASDAQ:GTLB), purchasing a total of 94,524 shares valued at $5,316,975. The shares were bought through both ARKK and ARKW ETFs, indicating a strong confidence in the company’s growth prospects.
Another significant buy for ARK was the addition of 106,033 shares of sports data and technology company Genius Sports Ltd (NYSE:GENI) through its ARKW ETF, amounting to $882,194. This continues a trend of ARK showing interest in the sports technology sector.
In the streaming device sector, ARK reduced its position in Roku Inc (NASDAQ:ROKU) by selling 51,009 shares through ARKW ETF, totaling $4,093,982. This sell-off follows previous trading sessions where ARK has been observed trimming its holdings in the company.
Financial services and tech company SoFi Technologies Inc (NASDAQ:SOFI) also saw a reduction in ARK’s investment, with 75,613 shares sold through the ARKF ETF, equating to $1,026,068. This follows a larger sale of SoFi shares by ARK last week, suggesting a consistent sell-down in this position.
Less significant trades included the sale of 9,570 shares of online betting company DraftKings Inc (NASDAQ:DKNG), which ARK offloaded for $398,016 through its ARKF ETF, and a minor sale of 265 shares of cancer screening company Exact Sciences Corp (NASDAQ:EXAS) for $12,600 through the ARKG ETF.
Reviewing the past week’s transactions, ARK has been actively managing its portfolio with a mix of buys and sells across various sectors. Notably, ARK has been accumulating shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) and Tempus AI Inc (NASDAQ:TEM) while reducing its exposure to DraftKings Inc (NASDAQ:DKNG) and Roku Inc (NASDAQ:ROKU) over recent days, indicating a strategic shift in its investment focus.
Investors and market watchers closely follow Cathie Wood’s ARK ETF trades, as they often signal broader trends and shifts in the innovative and disruptive technology sectors that ARK is known for targeting. Today’s trades provide further insights into the firm’s latest strategic moves and areas of focus.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.